ZA914339B - ((1-arylpyrrolidin-2-yl)methyl)piperazine derivates,their preparation and their application in therapeutics - Google Patents

((1-arylpyrrolidin-2-yl)methyl)piperazine derivates,their preparation and their application in therapeutics

Info

Publication number
ZA914339B
ZA914339B ZA914339A ZA914339A ZA914339B ZA 914339 B ZA914339 B ZA 914339B ZA 914339 A ZA914339 A ZA 914339A ZA 914339 A ZA914339 A ZA 914339A ZA 914339 B ZA914339 B ZA 914339B
Authority
ZA
South Africa
Prior art keywords
group
denotes
formula
arylpyrrolidin
methyl
Prior art date
Application number
ZA914339A
Other languages
English (en)
Inventor
Pascal George
George Pascal
Jean-Pierre Merly
Merly Jean-Pierre
Daniel Obitz
Obitz Daniel
Corinne Veronique
Veronique Corinne
Jacques Menin
Menin Jacques
Dennis Bigg
Bigg Dennis
Michel Peynot
Peynot Michel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA914339B publication Critical patent/ZA914339B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA914339A 1990-06-07 1991-06-06 ((1-arylpyrrolidin-2-yl)methyl)piperazine derivates,their preparation and their application in therapeutics ZA914339B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007067A FR2663026B1 (fr) 1990-06-07 1990-06-07 Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ZA914339B true ZA914339B (en) 1992-03-25

Family

ID=9397358

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914339A ZA914339B (en) 1990-06-07 1991-06-06 ((1-arylpyrrolidin-2-yl)methyl)piperazine derivates,their preparation and their application in therapeutics

Country Status (21)

Country Link
US (1) US5192763A (fi)
EP (1) EP0461012B1 (fi)
JP (1) JPH04235958A (fi)
KR (1) KR100188902B1 (fi)
AT (1) ATE104662T1 (fi)
AU (1) AU634391B2 (fi)
CA (1) CA2043981A1 (fi)
CS (1) CS173691A3 (fi)
DE (1) DE69101740T2 (fi)
DK (1) DK0461012T3 (fi)
ES (1) ES2054460T3 (fi)
FI (1) FI97055C (fi)
FR (1) FR2663026B1 (fi)
HU (1) HU209620B (fi)
IE (1) IE64688B1 (fi)
IL (1) IL98372A (fi)
NO (1) NO177931C (fi)
NZ (1) NZ238431A (fi)
PL (1) PL165187B1 (fi)
PT (1) PT97885B (fi)
ZA (1) ZA914339B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245712B (it) * 1991-04-09 1994-10-14 Boehringer Mannheim Italia Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
FR2684374B1 (fr) * 1991-12-02 1995-05-19 Synthelabo Derives substitues de 1-[(1-arylpyrrolidin-2-yl)methyl]piperazine, leur preparation et leur application en therapeutique.
IT1255704B (it) * 1992-09-30 1995-11-10 Boehringer Mannheim Italia Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250771A (en) * 1962-12-17 1966-05-10 Geigy Chem Corp 5-monocarbocyclic aryl-n-lower alkyl-2-pyrrolidine carboxylic acid, esters, amides and derivatives thereof
GB1428493A (en) * 1973-05-02 1976-03-17 Science Union & Cie Heterocyclic amides processes for their preparation and pharma ceutical compositions containing them
US5063242A (en) * 1989-04-21 1991-11-05 Warner-Lambert Company 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents

Also Published As

Publication number Publication date
DK0461012T3 (da) 1994-09-12
EP0461012A1 (fr) 1991-12-11
IL98372A (en) 1996-01-31
US5192763A (en) 1993-03-09
ES2054460T3 (es) 1994-08-01
NO912168D0 (no) 1991-06-06
HUT58070A (en) 1992-01-28
KR100188902B1 (ko) 1999-06-01
PL165187B1 (pl) 1994-11-30
DE69101740D1 (de) 1994-05-26
NO177931B (no) 1995-09-11
JPH04235958A (ja) 1992-08-25
AU7819691A (en) 1991-12-12
IE64688B1 (en) 1995-08-23
EP0461012B1 (fr) 1994-04-20
PL290572A1 (en) 1992-02-10
HU911895D0 (en) 1991-12-30
FR2663026A1 (fr) 1991-12-13
FI97055B (fi) 1996-06-28
NZ238431A (en) 1992-09-25
DE69101740T2 (de) 1994-10-20
FI912733A0 (fi) 1991-06-06
FI97055C (fi) 1996-10-10
KR920000751A (ko) 1992-01-29
FI912733A (fi) 1991-12-08
CS173691A3 (en) 1992-02-19
IE911941A1 (en) 1991-12-18
PT97885B (pt) 1998-10-30
NO177931C (no) 1995-12-20
HU209620B (en) 1994-09-28
CA2043981A1 (en) 1991-12-08
NO912168L (no) 1991-12-09
FR2663026B1 (fr) 1992-08-07
AU634391B2 (en) 1993-02-18
ATE104662T1 (de) 1994-05-15
IL98372A0 (en) 1992-07-15
PT97885A (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
EP0409406A3 (en) Aryl-substituted amine derivatives useful in cancer therapy
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
CO4340691A1 (es) 2-HETEROARIL-5,11-DIHIDRO-6H-DIPIRIDO(3,2-b:2´, 3´ -e) (1, 4)-DIAZEPINAS .
AU536912B2 (en) Benzothiazole derivatives
ZA914339B (en) ((1-arylpyrrolidin-2-yl)methyl)piperazine derivates,their preparation and their application in therapeutics
ATE100103T1 (de) 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
GR3020292T3 (en) Use of 2-iminothiazolidin-4-one derivatives as new medicaments
IE901104L (en) New bronchospasmolytic compounds and process for their¹preparation
SE8800863L (sv) 3-(2-haloalkyl)-1,4-oxatiiner och 2-(2-haloalkyl)1,4-ditiiner och bahandling av leukemi och tumoerer daermed
JPS57188566A (en) 2-(3-(3-indolyl)-2-amino-propionyloxy)acetic acid derivative, manufacture and medicine containing same
SE8302452D0 (sv) Method for treatment of senile dementia
IL67564A (en) 7-heteroaryl-(1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
GR80903B (en) Process for the preparation of novel thieno (2,3-b) pyrrole derivatives
JO1635B1 (en) New compounds to shrink the people and a process to prepare them